Search Results 21-30 of 17607 for Obesity/Overweight Treatment
Treatment with study drug is for 12 weeks, including the titration period, with a 4-week post-treatment follow-up period. Participation eligibility.
Obesity is a life-limiting disorder associated with a number of comorbidities. Currently more than two-thirds of Americans are overweight (BMI ≥ 25 kg/m2) ...
A higher BMI also may be linked to a greater risk of a fertility treatment called in vitro fertilization not working. How might a high BMI affect my pregnancy?
Weight-loss surgery is one part of a treatment ... BMI is a formula that uses weight and height to estimate body fat ... BMI of 40 or higher and any obesity-related ...
Acosta and a team of Mayo Clinic researchers set out to study anti-obesity medications based on obesity phenotypes to enhance weight loss. Their findings, ...
... treatment of overweight and obesity in the clinical setting.” Dr. Croghan, although optimistic about the potential of LLLT, cautions, “While exploring this ...
Your body mass index (BMI) is 40 or higher (extreme obesity). ... overweight, including: Gastroesophageal ... Management of morbid obesity. In: Current ...
Referral considerations for physicians treating patients with high BMI who require arthroplasty. Dr. Bedard indicates multiple options exist for physicians ...
... fat in overweight/obese individuals; 2) impact of LLLT on inflammatory biomarkers, blood sugar, and cholesterol. Participation eligibility. Participant ...
... obesity management remains challenging. Diet and exercise often don't produce significant and sustained weight loss. And although bariatric surgery produces ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
The deadline to have twice the impact to advance healthcare research is May 15.